Medicare Analysis – Shows Savings From Multiple Sclerosis Treatment

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis

January 4, 2011


A breakthrough analysis of multiple sclerosis (MS) costs highlights the rapidly escalating economic burden as the disease advances.

New therapies for multiple sclerosis require economic justification. Progress in controlling this disease therefore depends on understanding how medical costs evolve over time.

JEN Associates and Wyeth researchers conducted a novel computer analysis to sort MS patients by disease stage based on their Medicare payment records. This objective MS classification method led to a deeper understanding of MS medical costs. The results indicate the savings that Medicare could reap if treatment blocked MS’s usual steady advance. 


READ MORE from Medical News today

***************************************************************
If you find our information valuable, 
please donate by clicking here 
all contributions are tax deductible
****************************************************************
Providing You with ‘MS Views and News’is what we do

.

REMAIN uptodate with educational information of
 Multiple Sclerosis when registered at
the MS Views and News  website.

.

****************************************************************
Disclaimer:  ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews